Aflatoxin M1 contamination of human breast milk in Isfahan, Iran

Authors
Abbas Jafarian-Dehkordi
Nasibeh Pourradi
Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: During the last decades there has been great attention paid to aflatoxins. They are highly toxic, immunosuppressive, mutagenic, teratogenic, and carcinogenic compounds. Aflatoxin M 1 (AFM1), a hydroxylated metabolite of aflatoxin B 1 (AFB1), is formed in the liver and excreted into the breast milk. It is considered to cause certain hygienic risks for infant health. The aim of this study was to evaluate the presence of the AFM1 in the breast milk using AFM1 in milk as a biomarker for exposure to aflatoxin B 1 and determine the level of AFM1 contamination in the lactating mothers in Isfahan, Iran.
Materials and Methods: This study was carried out on 80 lactating women randomly selected from two urban health centers. Mother's milk samples and information on food intake were collected from the participants using structured food-frequency questionnaire. Breast milk samples were tested for AFM1 by a competitive ELISA technique.
Results: Our findings showed that only one sample was contaminated with AFM1 with concentrations of 6.8 ng/L. However, the AFM1 level in this sample was lower than the maximum tolerable limit (25 ng/L) accepted by the European Communities and Codex Alimentarius.
Conclusion: Although the concentration of AFM1 in none of the samples was higher than the acceptable level, the presence of AFM1 in only one of them confirms the need for developing strategies to reduce exposure to aflatoxin in foods and to carry out biological monitoring of aflatoxins as a food quality control measure routinely.

Keywords

1. Sancho GC, Marin S, Ramos AJ, Vicente JP, Sanchis V. Occurrence of aflatoxin M 1 and exposure assessment in Catalonia, Spain. Rev Iberoam Micol 2010;27:130-5.  Back to cited text no. 1
    
2. Tchana AN, Moundipa PF, Tchouanguep FM. Aflatoxin contamination in food and body fluids in relation to malnutrition and cancer status in Cameroon. Int J Environ Res Public Health 2010;7:178-88.  Back to cited text no. 2
[PUBMED]    
3. Pirestani A, Toghyani M. The effect of aflatoxin levels on milk production, reproduction and lameness in high production Holstein cows. Afr J Biotechnol 2010;9:7905-8.  Back to cited text no. 3
    
4. Paniel N, Radoi A, Marty JL. Development of an electrochemical biosensor for the detection of aflatoxin M 1 in milk. Sensors (Basel) 2010;10:9439-48.  Back to cited text no. 4
[PUBMED]    
5. Lopez CE, Ramos LL, Ramadan SS, Bulacio LC. Presence of aflatoxin M 1 in milk for human consumption in Argentina. Food Control 2003;14:31-4.  Back to cited text no. 5
    
6. Williams JH, Phillips DT, Jolly PE, Stiles JK, Jolly CM, Aggaewal D. Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and intervention. Am J Clin Nutr 2004;80:1106-22.  Back to cited text no. 6
    
7. Creppy EE. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol Lett 2002;127:19-28.  Back to cited text no. 7
[PUBMED]    
8. IARC, International Agency for Research on Cancer. Monograph on the evaluation of carcinogenic risk to humans, World Health Organization, some traditional herbal medicines, some mycotoxins, naphthalene and styrene. In: Summary of data reported and evaluation. Vol. 82. CEDEX: Lyon, International Agency for Research on Cancer: 2002. p. 171-5.  Back to cited text no. 8
    
9. Dänicke S, Fink-Gremmels J, van Egmond H, Gilbert J, Larsen JC, Leibetseder J, et al. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to Aflatoxin B 1 as undesirable substance in animal feed. EFSA J 2004;39:1-27.  Back to cited text no. 9
    
10. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus flavus: Human pathogen, allergen and mycotoxin producer. Microbiology 2007;153:1677-92.  Back to cited text no. 10
[PUBMED]    
11. Rahimi E, Shakerian A, Jafariyan M, Ebrahimi M, Riahi M. Occurrence of aflatoxin M 1 in raw, pasteurized and UHT milk commercialized in Esfahan and Shahr-e Kord, Iran. Food Sci 2009;1:317-20.  Back to cited text no. 11
    
12. Fallah AA, Jafari T, Fallah A, Rahnama M. Determination of aflatoxin M 1 levels in Iranian white and cream cheese. Food Chem Toxicol 2009;47:1872-5.  Back to cited text no. 12
[PUBMED]    
13. Oveisi M, Jannat B, Sadeghi N. Incidence of aflatoxin M 1 in human breast milk in Tehran, Iran. Food Control 2009;20:75-8.  Back to cited text no. 13
    
14. Rastogi S, Dwivedi PD, Khanna SK, Das M. Detection of aflatoxin M 1 contamination in milk and infant milk products from Indian markets by ELISA. Food Control 2004;15:287-90.  Back to cited text no. 14
    
15. Heshmati A, Milani JM. Contamination of UHT milk by aflatoxin M 1 in Iran. Food Control 2010;21:19-22.  Back to cited text no. 15
    
16. Turconi G, Guarcello M, Livieri S. Evaluation of Xenobiotics in human breast milk and ingestion by the newborn. Eur J Nutr 2004;43:191-7.  Back to cited text no. 16
    
17. Heidarinia A. Detection of aflatoxin M 1 in breast milk. PhD thesis, Faculty of Medicine, Ahvaz University, Ahvaz, Iran, 1995. pp. 57-63.  Back to cited text no. 17
    
18. Navasi SA, Sabino M, Rodriguez DB. Aflatoxin M 1 and ochratoxin A in a human milk bank in the city of São Paulo, Brazil. Food Addit Contam 2005;22:457-62.  Back to cited text no. 18
    
19. Gurbay A. Exposure of newborns to aflatoxin M 1 and B 1 from mothers' breast milk in Ankara, Turkey. Food Chem Toxicol 2010;48:314-9.  Back to cited text no. 19
    
20. El-Nezami H, Nicoletti G, Neal GE, Donohue DC, Ahokas JT. Aflatoxin M 1 in human breast milk samples from Victoria, Australia and Thailand. Food Chem Toxicol 1995;33:173-9.  Back to cited text no. 20
    
21. Oveisi M, Jannat B, Sadeghi N, Hajimahmoodi M, Nikzad A. Presence of aflatoxin M 1 in milk and infant milk products in Tehran, Iran. Food Control 2007;18:1216-8.  Back to cited text no. 21
    
 
Advanced Biomedical Research
Volume 2013, November
November 2013
Pages 1-4